Tech Center 1600 • Art Units: 1652
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17916441 | ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF | Final Rejection | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 17683101 | METHODS AND COMPOSITIONS FOR 3-HYDROXYPROPIONATE PRODUCTION | Non-Final OA | The Regents of the University of California |
| 18419342 | ENHANCING THE SEQUESTRATION OF CARBON DIOXIDE IN DOWNHOLE CARBONATE-BASED RESERVOIRS VIA INJECTING UREASE ENZYME | Non-Final OA | SAUDI ARABIAN OIL COMPANY |
| 18031691 | RELATIVE UNPAIRED GLYCANS IN ANTIBODY PRODUCTION METHODS | Non-Final OA | AMGEN INC. |
| 19275193 | IMMOBILIZED ENZYMES FOR THE BIOELECTRIC PRODUCTION OF FORMATE AND FORMIC ACID | Non-Final OA | Anodyne Chemistries, Inc. |
| 18265094 | ENZYME BASED PRODUCTION OF SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) VIA DOCOSAHEXAENOIC ACID (DHA) AND EICOSAPENTAENOIC ACID (EPA) | Non-Final OA | Evonik Operations GmbH |
| 18005086 | POLYNUCLEOTIDE ENCODING AN AMINO ACID SEQUENCE, ENCODING AN OXIDOREDUCTASE | Non-Final OA | Evonik Operations GmbH |
| 18262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | Non-Final OA | Kashiv BioSciences, LLC |
| 18555956 | ENZYMATICALLY-CLEAVABLE GLYCIDYL METHACRYLATE HYALURONIC ACID | Final Rejection | University of Florida Research Foundation, Inc. |
| 18002239 | NOVEL TRANSGLUTAMINASE | Final Rejection | THE UNIVERSITY OF TOKYO |
| 18976903 | SINGLE CELL PROTEIN WITH ENHANCED POLYUNSATURATED FATTY ACID CONTENT | Final Rejection | LanzaTech, Inc. |
| 17794137 | MICROORGANISM WITH ENHANCED L-BRANCHED-CHAIN AMINO ACID PRODUCING ABILITY AND METHOD FOR PRODUCING L-BRANCHED-CHAIN AMINO ACID USING SAME | Final Rejection | CJ CHEILJEDANG CORPORATION |
| 18191994 | MUTANT TRANSGLUTAMINASE | Non-Final OA | AJINOMOTO CO., INC. |
| 17642974 | Detergent Composition | Final Rejection | Novozymes A/S |
| 18720533 | PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS | Final Rejection | INBIOSE N.V. |
| 17910952 | TRANSGLUTAMINASE VARIANTS | Non-Final OA | Curie Co. Inc. |
| 18683749 | POLYNUCLEOTIDES ENCODING NOVEL NUCLEASES, COMPOSITIONS THEREOF AND METHODS THEREOF FOR ELIMINATING DNA FROM PROTEIN PREPARATIONS | Non-Final OA | DANISCO US INC. |
| 17623086 | MODIFIED YEAST CELLS THAT OVER-EXPRESS SELECTED ENDOGENOUS PROTEINS | Non-Final OA | DANISCO US INC |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | Non-Final OA | UNIVERSITE PARIS-SACLAY |
| 18266282 | LYSOSOMAL ACID LIPASE VARIANTS AND USES THEREOF | Non-Final OA | UNIVERSITE PARIS-SACLAY |
| 18012979 | ENZYME-IMMOBILIZATION CARRIER AND IMMOBILIZED ENZYME THAT USES SAME | Final Rejection | FUJI OIL HOLDINGS INC. |
| 18546061 | FUSION PROTEINS COMPRISING A PROTEIN WITH PHASE BEHAVIOR | Non-Final OA | Donaldson Company, Inc. |
| 17997932 | PECTIN EXTRACTION PROCESS | Final Rejection | DUPONT NUTRITION BIOSCIENCES APS |
| 18425681 | CELL-TARGETED CYTOTOXIC CONSTRUCTS | Non-Final OA | RESEARCH DEVELOPMENT FOUNDATION |
| 18416322 | COMPOSITIONS AND METHODS FOR AMINO ACID DEPLETION THERAPY | Final Rejection | AVALON POLYTOM (HK) LIMITED |
| 17607543 | METHODS FOR PRODUCTION OF ERGOTHIONEINE | Non-Final OA | Danmarks Tekniske Universitet |
| 18068004 | BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA | Non-Final OA | Synlogic Operating Company, Inc. |
| 17843589 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Non-Final OA | Genomatica, Inc. |
| 16767920 | METHODS OF TREATMENT WITH ASPARAGINASE | Non-Final OA | JAZZ PHARMACEUTICALS IRELAND LTD. |
| 18282403 | ANTIMICROBIAL COMPOSITIONS | Non-Final OA | Matoke Holdings Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy